Prediction of disease-related interactions between microRNAs and environmental factors based on a semi-supervised classifier

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Chen, Xing ^a,b   Liu, Ming Xi ^b,c   Cui, Qing Hua ^d   Yan, Gui Ying ^a,b  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b CHINESE ACADEMY OF SCIENCES   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^d PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; MICRORNA; MICRORNA 15A; MICRORNA 16; RETINOIC ACID;

ACCURACY; ACUTE GRANULOCYTIC LEUKEMIA; AREA UNDER THE CURVE; ARTICLE; CLASSIFIER; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INTERMETHOD COMPARISON; MIREFSCAN; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; SENSITIVITY AND SPECIFICITY; VALIDITY;

COMPUTATIONAL BIOLOGY; ENVIRONMENTAL EXPOSURE; HUMANS; MICRORNAS; MODELS, THEORETICAL;

EID: 84865295522     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043425     Document Type: Article

References (52)

1. Barabasi AL, Gulbahce N, Loscalzo J, (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet 12: 56-68.
2. Soto AM, Sonnenschein C, (2010) Environmental causes of cancer: endocrine disruptors as carcinogens. Nature Reviews Endocrinology 6: 364-371.
3. Chow WH, Dong LM, Devesa SS, (2010) Epidemiology and risk factors for kidney cancer. Nat Rev Urol 7: 245-257.
4. Das UN, (2010) Obesity: genes, brain, gut, and environment. Nutrition 26: 459-473.
5. Yildirim MA, Goh KI, Cusick ME, Barabasi AL, Vidal M, (2007) Drug-target network. Nature Biotechnology 25: 1119-1126.
6. Overington JP, Al-Lazikani B, Hopkins AL, (2006) Opinion- How many drug targets are there? Nature Reviews Drug Discovery 5: 993-996.
7. Landry Y, Gies JP, (2008) Drugs and their molecular targets: an updated overview. Fundamental Clinical Pharmacology 22: 1-18.
8. Drews J, (2000) Drug discovery: a historical perspective. Science 287: 1960-1964.
9. Chen X, Liu MX, Yan GY, (2012) Drug-target interaction prediction by random walk on the heterogeneous network. Mol Biosyst 8: 1970-1978.
10. Campillos M, Kuhn M, Gavin AC, Jensen LJ, Bork P, (2008) Drug target identification using side-effect similarity. Science 321: 263-266.
11. Dudley JT, Deshpande T, Butte AJ, (2011) Exploiting drug-disease relationships for computational drug repositioning. Brief Bioinform 12: 303-311.
12. Frantz S, (2005) Drug discovery: playing dirty. Nature 437: 942-943.
13. Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, et al. (2009) Predicting new molecular targets for known drugs. Nature 462: 175-181.
14. Cui Q, Yu Z, Purisima EO, Wang E, (2006) Principles of microRNA regulation of a human cellular signaling network. Mol Syst Biol 2: 46.
15. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
16. Esquela-Kerscher A, Slack FJ, (2006) Oncomirs- microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
17. Lu M, Zhang QP, Deng M, Miao J, Guo YH, et al. (2008) An Analysis of Human MicroRNA and Disease Associations. PLoS One 3: e3420.
18. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
19. Latronico MV, Catalucci D, Condorelli G, (2007) Emerging role of microRNAs in cardiovascular biology. Circ Res 101: 1225-1236.
20. Catania AS, Barros CR, Ferreira SR, (2009) [Vitamins and minerals with antioxidant properties and cardiometabolic risk: controversies and perspectives]. Arq Bras Endocrinol Metabol 53: 550-559.
21. Alisi A, Da Sacco L, Bruscalupi G, Piemonte F, Panera N, et al. (2011) Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease. Lab Invest 91: 283-293.
22. Gidron Y, De Zwaan M, Quint K, Ocker M, (2010) Influence of stress and health-behaviour on miRNA expression. Mol Med Report 3: 455-457.
23. Izzotti A, Larghero P, Cartiglia C, Longobardi M, Pfeffer U, et al. (2010) Modulation of microRNA expression by budesonide, phenethyl isothiocyanate and cigarette smoke in mouse liver and lung. Carcinogenesis 31: 894-901.
24. Jardim MJ, (2011) microRNAs: implications for air pollution research. Mutat Res 717: 38-45.
25. Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, et al. (2008) MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47: 1955-1963.
26. Lima RT, Busacca S, Almeida GM, Gaudino G, Fennell DA, et al. (2011) MicroRNA regulation of core apoptosis pathways in cancer. Eur J Cancer 47: 163-174.
27. Lin Z, Flemington EK, (2011) miRNAs in the pathogenesis of oncogenic human viruses. Cancer Lett 305: 186-199.
28. Niemoeller OM, Niyazi M, Corradini S, Zehentmayr F, Li M, et al. (2011) MicroRNA expression profiles in human cancer cells after ionizing radiation. Radiat Oncol 6: 29.
29. Jafarifar F, Yao P, Eswarappa SM, Fox PL, (2011) Repression of VEGFA by CA-rich element-binding microRNAs is modulated by hnRNP L. Embo Journal. 30: 1324-1334.
30. Xi S, Yang M, Tao Y, Xu H, Shan J, et al. (2010) Cigarette smoke induces C/EBP-beta-mediated activation of miR-31 in normal human respiratory epithelia and lung cancer cells. PLoS One 5: e13764.
31. Jiang J, Zheng X, Xu X, Zhou Q, Yan H, et al. (2011) Prognostic significance of miR-181b and miR-21 in gastric cancer patients treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin. PLoS One 6: e23271.
32. Boren T, Xiong Y, Hakam A, Wenham R, Apte S, et al. (2009) MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy. Gynecol Oncol 113: 249-255.
33. Yang Q, Qiu C, Yang J, Wu Q, Cui Q, (2011) miREnvironment database: providing a bridge for microRNAs, environmental factors and phenotypes. Bioinformatics 27: 3329-3330.
34. Qiu CX, Chen G, Cui QH (2012) Towards the understanding of microRNA and environmental factor interactions and their relationships to human diseases. Sci Rep 2.
35. Yamanishi Y, Kotera M, Kanehisa M, Goto S, (2010) Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework. Bioinformatics 26: i246-254.
36. van Laarhoven T, Nabuurs SB, Marchiori E, (2011) Gaussian interaction profile kernels for predicting drug-target interaction. Bioinformatics 27: 3036-3043.
37. Hattori M, Okuno Y, Goto S, Kanehisa M, (2003) Development of a chemical structure comparison method for integrated analysis of chemical and genomic information in the metabolic pathways. J Am Chem Soc 125: 11853-11865.
38. Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, et al. (2006) From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 34: D354-357.
39. Bolton EE, Wang Y, Thiessen PA, Bryant SH (2008) Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities. In: Ralph AW, David CS, editors. Annual Reports in Computational Chemistry: Elsevier. 217-241.
40. Wang D, Wang J, Lu M, Song F, Cui Q, (2010) Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases. Bioinformatics 26: 1644-1650.
41. Belkin M, Niyogi P, Sindhwani V, (2006) Manifold regularization: A geometric framework for learning from labeled and unlabeled examples. Journal of Machine Learning Research 7: 2399-2434.
42. Xia Z, Wu LY, Zhou X, Wong ST, (2010) Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces. Bmc Systems Biology 4 (Suppl 2): S6.
43. Li Y, Zhu X, Gu J, Hu H, Dong D, et al. (2010) Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis. Hematology 15: 215-221.
44. Tang Y, Banan A, Forsyth CB, Fields JZ, Lau CK, et al. (2008) Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. Alcohol Clin Exp Res 32: 355-364.
45. Ivan M, Harris AL, Martelli F, Kulshreshtha R, (2008) Hypoxia response and microRNAs: no longer two separate worlds. J Cell Mol Med 12: 1426-1431.
46. Pandolfi PP, Vogt PK (2007) Acute promyelocytic leukemia: molecular genetics, mouse models and targeted therapy: Springer Verlag.
47. Davis CD, Ross SA, (2008) Evidence for dietary regulation of microRNA expression in cancer cells. Nutr Rev 66: 477-482.
48. Gu J, Zhu X, Li Y, Dong D, Yao J, et al. (2011) miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines. Med Oncol 28: 211-218.
49. Ghaffari SH, Bashash D, Dizaji MZ, Ghavamzadeh A, Alimoghaddam K, (2012) Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action. Tumour Biol 33: 157-172.
50. Gao SM, Chen CQ, Wu JB, Tan YX, Yu K, et al. (2010) Synergistic apoptosis induction in leukemic cells by miR-15a/16-1 and arsenic trioxide. Biochem Biophys Res Commun 403: 203-208.
51. Aerts S, Lambrechts D, Maity S, Van Loo P, Coessens B, et al. (2006) Gene prioritization through genomic data fusion. Nature Biotechnology 24: 537-544.
52. Chen X, Yan GY, Liao XP, (2010) A novel candidate disease genes prioritization method based on module partition and rank fusion. OMICS 14: 337-356.